Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-8448b6f56d-sxzjt Total loading time: 0 Render date: 2024-04-18T01:13:00.149Z Has data issue: false hasContentIssue false

18 - Tuberculosis

from Section 4 - Major common infections

Published online by Cambridge University Press:  05 March 2013

By
Anthony D. Harries ,
Rony Zachariah ,
Rhehab Chimzizi ,
Felix M. Salaniponi  and
Stephen D. Lawn
Edited by
David Mabey ,
Geoffrey Gill ,
Eldryd Parry ,
Martin W. Weber  and
Christopher J. M. Whitty
David Mabey
Affiliation:
London School of Hygiene and Tropical Medicine
Geoffrey Gill
Affiliation:
University of Liverpool
Eldryd Parry
Affiliation:
Tropical Health Education Trust
Martin W. Weber
Affiliation:
World Health Organization, Jakarta
Christopher J. M. Whitty
Affiliation:
London School of Hygiene and Tropical Medicine
Get access

Summary

The problem in Africa

Tuberculosis (TB) is one of the most serious threats to public and individual health in Africa. In 1993, the World Health Organization (WHO) took the unprecedented step of declaring TB to be a global emergency. Since then, despite the WHO's Stop TB Strategy and significant strides taken in scaling up TB diagnostic and treatment services, control of the global TB pandemic has remained elusive. In 2008, there were an estimated 9.4 million TB cases globally and close to 1.8 million TB deaths (WHO, 2009a). Africa has the highest burden of disease per head of population, with an estimated incidence rate of 363 TB cases per 100 000. The driving force behind the African TB epidemic is the other major epidemic of human immunodeficiency virus (HIV) infection. Not only has HIV been responsible for the tremendous increase in numbers of TB cases seen in the region in the last 15 years, but it threatens TB control efforts by further stigmatizing the disease, complicating the diagnosis, reducing the effectiveness of treatment, increasing TB recurrence rates and facilitating the spread of drug-resistant disease.

In this chapter we discuss the epidemiology, pathogenesis, clinical features, diagnosis, treatment and prevention of TB, and explain how this fits together within a framework for TB control. In all these areas, we emphasize the strong link with HIV. The best chance of detecting the disease, curing the patients and halting transmission lies in having a strong countrywide TB control programme and effective collaborative activities with prevention and treatment of HIV, and we highlight how these should work.

Type
Chapter
Information
Principles of Medicine in Africa , pp. 232 - 253
Publisher: Cambridge University Press
Print publication year: 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ait-Khaled, N, Alarcon, E, Bissell, K et al. (2009). Isoniazid preventive therapy for people living with HIV: public health challenges and implementation issues. Int J Tuberc Lung Dis; 13: 927–35.Google ScholarPubMed
Badri, M, Wilson, D, Wood, R. (2002). Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet; 359: 2059–64.CrossRefGoogle ScholarPubMed
Cain, KP, McCarthy, KD, Heilig, CM et al. (2010). An algorithm for tuberculosis screening and diagnosis in people with HIV. N Engl J Med; 362: 707–16.CrossRefGoogle Scholar
Colebunders, R, Bastian, I. (2000). A review of the diagnosis and treatment of smear-negative pulmonary tuberculosis. Int J Tuberc Lung Dis; 4: 97–107.Google ScholarPubMed
Corbett, EL, Watt, CJ, Walker, N et al. (2003). The growing burden of tuberculosis. Global trends and interactions with the HIV epidemic. Arch Intern Med; 163: 1009–21.CrossRefGoogle ScholarPubMed
Corbett, EL, Marston, B, Churchyard, GJ, De Cock, KM. (2006). Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet; 367: 926–37.CrossRefGoogle ScholarPubMed
Daniel, TM. (1998). The early history of tuberculosis in central East Africa: insights from the clinical records of the first twenty years of Mengo Hospital and review of relevant literature. Int J Tuberc Lung Disease; 2: 784–90.Google ScholarPubMed
De Cock, KM, Chaisson, RE. (1999). Will DOTS do it? A reappraisal of tuberculosis control in countries with high rates of HIV infection. Int J Tuberc Lung Dis; 3: 457–65.Google ScholarPubMed
Diul, MY, Maher, D, Harries, AD. (2001). Tuberculosis case fatality rates in HIV prevalence populations in sub-Saharan Africa. AIDS; 15:143–52.Google Scholar
Escombe, AR, Oeser, CC, Gilman, RH et al. (2007). Natural ventilation for the prevention of airborne contagion. PLoS Med; 4: e68.CrossRefGoogle ScholarPubMed
Gandhi, NR, Moll, A, Sturm, W et al. (2006). Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet; 368: 1575–80.CrossRefGoogle Scholar
Global Advisory Committee on vaccine safety. Revised BCG vaccination guidelines for infants at risk for HIV infection. 25th May 2007. Wkly Epidemiol Rec 2007; 82: 181–96.Google Scholar
Golub, JE, Pronyk, P, Mohapi, L et al. (2009). Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort. AIDS; 23: 631–6.CrossRefGoogle ScholarPubMed
Granich, RM, Gilks, CF, Dye, C, De Cock, KM, Williams, BG. (2009). Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet; 373: 48–57.CrossRefGoogle ScholarPubMed
Grant, A, Gothard, P, Thwaites, G. (2008). Managing drug resistant tuberculosis. BMJ; 337: 564–9.CrossRefGoogle ScholarPubMed
Hakim, JGTernouth, IMushangi, E et al. (2000). Double blind randomised placebo controlled trial of adjunctive prednisolone in the treatment of effusive tuberculous pericarditis. Heart; 84: 183–8.CrossRefGoogle ScholarPubMed
Harries, AD, Zachariah, R, Lawn, SD. (2009). Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa (State of the ART). Int J Tuberc Lung Dis; 13:6–16.Google Scholar
Hesseling, AC, Johnson, LF, Jaspan, H et al. (2009). Disseminated bacilli Calmette-Guerin disease in HIV-infected South African infants. Bull World Health Organ; 87: 505–11.CrossRefGoogle Scholar
Jindani, A, Nunn, AJ, Enarson, DA. (2004). Two 8-month regimens of chemotherapy for treatment of newly diagnosed pulmonary tuberculosis: international multicentre randomised trial. Lancet; 364: 1244–51.CrossRefGoogle ScholarPubMed
Karim, SSA, Churchyard, G, Karim, QA, Lawn, SD. (2009). HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response. Lancet; 374: 921–33.CrossRefGoogle Scholar
Korenromp, EL, Scano, F, Williams, BG, Dye, C, Nunn, P. (2003). Effects of human immunodeficiency virus infection on recurrence of tuberculosis after rifampicin-based treatment: an analytic review. Clin Infect Dis; 37: 101–112.CrossRefGoogle Scholar
Kranzer, K, Houben, R M G J, Glynn, JR, Bekker, LG, Wood, R, Lawn, SD. (2010). Yield of HIV associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis. Lancet Infect Dis; 10: 93–102.CrossRefGoogle ScholarPubMed
Lambert, ML, Hasker, E, van Deun, A, Roberfroid, D, Boelaert, M, van der Stuyft, P. (2003). Reucrrence in tuberculosis: relapse or reinfection?Lancet Infect Dis; 3: 282–7.CrossRefGoogle ScholarPubMed
Lawn, SD, Myer, L, Bekker, LG, Wood, R. (2006). Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS; 20: 1605–12.CrossRefGoogle Scholar
Lawn, SD, Myer, L, Bekker, LG, Wood, R. (2007). Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact within an antiretroviral treatment programme in sub-Saharan Africa. AIDS; 21: 335–41.CrossRefGoogle Scholar
Lawn, SD, Myer, L, Edwards, D, Bekker, LG, Wood, R. (2009). Short-term and long-term risk of tuberculosis associated with CD4 cell recovery during antiretroviral therapy in South Africa. AIDS; 23:1717–25.CrossRefGoogle ScholarPubMed
Lucas, SB, De Cock, KMHounnou, A, et al. (1994). Contribution of tuberculosis to slim disease in Africa. BMJ; 308: 1531–3.CrossRefGoogle ScholarPubMed
Pithie, A, Chicksen, B. (1992). Fine-needle extrathoracic lymph-node aspiration in HIV-associated sputum-negative tuberculosis. Lancet; 340: 1504–5.CrossRefGoogle ScholarPubMed
Sonnenberg, P, Glynn, JR, Fielding, K, Murray, J, Godfrey-Faussett, P, Shearer, S. (2005). How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. J Infect Dis; 191:150–8.CrossRefGoogle Scholar
The Stop TB Strategy: building on and enhancing DOTS to meet the TB-related Millennium Development Goals. (2006). Geneva, Switzerland: World Health Organization. (WHO/HTM,STB,2006.368).Google Scholar
WHO and UNAIDS. (1998). Policy statement on preventive therapy against tuberculosis in people living with HIV. WHO/TB/98.255. UNAIDS/98.34. Geneva, Switzerland: WHO.Google Scholar
Wood, R, Liang, H, Wu, H et al. (2010). Changing prevalence of TB infection with increasing age in high TB burden townships in South Africa. Int J Tuberc Lung Dis; 14: 406–412.
World Health Organization (2004). Interim Policy on Collaborative TB/HIV Activities. Geneva: WHO. WHO/HTM/TB/2004. 330. WHO/HTM/HIV/2004.1.Google Scholar
World Health Organization (2006a). Guidelines on co-trimoxazole prophylaxis for HIV-related among children, adolescents and adults. Recommendations for a public health approach (2006) Available: .
World Health Organization. (2006b). Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach. 2006 Revision. Available: .
World Health Organization (2006c). The Global Plan To Stop TB 2006–2015. Stop TB Partnership, 2006.
World Health Organization (2009a). Global Tuberculosis Control. Epidemiology, Strategy, Financing. WHO/HTM/TB/2009.411.
World Health Organization (2009b). Guidelines for the Treatment of Tuberculosis, 4th edn. Geneva, Switzerland.Google Scholar
World Health Organization (2009c). Rapid advice: antiretroviral therapy for HIV infection in adults and adolescents. November 30, 2009. Available: .
World Health Organization (2009d). WHO policy on TB infection control in health-care facilities, congregate settings and households. WHO/HTM/TB/2009.419. 2009.Google Scholar
Zachariah, R, Massaquoi, M. (2006). Cotrimoxazole prophylaxis for HIV-positive TB patients in developing countries. Tropical Doctor; 36: 79–82.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×